These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23787811)

  • 1. Tyrosine kinase inhibition facilitates autophagic SNCA/α-synuclein clearance.
    Hebron ML; Lonskaya I; Moussa CE
    Autophagy; 2013 Aug; 9(8):1249-50. PubMed ID: 23787811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.
    Hebron ML; Lonskaya I; Moussa CE
    Hum Mol Genet; 2013 Aug; 22(16):3315-28. PubMed ID: 23666528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased parkin solubility is associated with impairment of autophagy in the nigrostriatum of sporadic Parkinson's disease.
    Lonskaya I; Hebron ML; Algarzae NK; Desforges N; Moussa CE
    Neuroscience; 2013 Mar; 232():90-105. PubMed ID: 23262240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
    Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
    Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy.
    Lopez-Cuina M; Guerin PA; Canron MH; Delamarre A; Dehay B; Bezard E; Meissner WG; Fernagut PO
    Mov Disord; 2020 Jul; 35(7):1163-1172. PubMed ID: 32291831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons.
    Burbidge K; Rademacher DJ; Mattick J; Zack S; Grillini A; Bousset L; Kwon O; Kubicki K; Simon A; Melki R; Campbell EM
    Autophagy; 2022 May; 18(5):1020-1048. PubMed ID: 34612142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.
    Su LY; Li H; Lv L; Feng YM; Li GD; Luo R; Zhou HJ; Lei XG; Ma L; Li JL; Xu L; Hu XT; Yao YG
    Autophagy; 2015; 11(10):1745-59. PubMed ID: 26292069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synucleinopathy associated c-Abl activation causes p53-dependent autophagy impairment.
    Karim MR; Liao EE; Kim J; Meints J; Martinez HM; Pletnikova O; Troncoso JC; Lee MK
    Mol Neurodegener; 2020 Apr; 15(1):27. PubMed ID: 32299471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A.
    Du TT; Wang L; Duan CL; Lu LL; Zhang JL; Gao G; Qiu XB; Wang XM; Yang H
    Autophagy; 2015; 11(10):1803-20. PubMed ID: 26378614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation.
    Yang YJ; Bu LL; Shen C; Ge JJ; He SJ; Yu HL; Tang YL; Jue Z; Sun YM; Yu WB; Zuo CT; Wu JJ; Wang J; Liu FT
    J Parkinsons Dis; 2020; 10(3):969-979. PubMed ID: 32568105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression.
    Pupyshev AB; Korolenko TA; Akopyan AA; Amstislavskaya TG; Tikhonova MA
    Neurosci Lett; 2018 Apr; 672():140-144. PubMed ID: 29203207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model.
    Lee S; Kim S; Park YJ; Yun SP; Kwon SH; Kim D; Kim DY; Shin JS; Cho DJ; Lee GY; Ju HS; Yun HJ; Park JH; Kim WR; Jung EA; Lee S; Ko HS
    Hum Mol Genet; 2018 Jul; 27(13):2344-2356. PubMed ID: 29897434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MANF Inhibits
    Zhang JX; Tong WF; Jiang M; Zhou KG; Xiang XR; He YJ; Zhang ZY; Guan Q; Jin LJ
    Oxid Med Cell Longev; 2022; 2022():7925686. PubMed ID: 35847585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synucleinphagy: a microglial "community cleanup program" for neuroprotection.
    Choi I; Seegobin SP; Liang D; Yue Z
    Autophagy; 2020 Sep; 16(9):1718-1720. PubMed ID: 32453651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance.
    Lonskaya I; Hebron ML; Desforges NM; Schachter JB; Moussa CE
    J Mol Med (Berl); 2014 Apr; 92(4):373-86. PubMed ID: 24337465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.